Zoetis IPO values Pfizer animal health business at up to $15.8bn
This article was originally published in Scrip
Executive Summary
Pfizer priced the initial public offering of 86.1 million shares of its animal health business, which will be spun out in a new company called Zoetis, at $22 to $25 per share in an amended S-1 form filed with the US Securities and Exchange Commission (SEC) on 17 January, valuing the company at about $11.8 billion at the mid-point of its price range, or $23.50 per share.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports